@BioStock_News profile picture
BioStock News @BioStock_News

BioStock is a digital news and analysis service focused on the Scandinavian Life Science sector based in Sweden. (For news in Swedish, check out @BioStock_SWE)

Joined January 2020
  • Tweets 772
  • Following 156
  • Followers 228
24 Photos and videos
Aptahem reports promising outcome from the additional analyses on the mechanism on lead candidate Apta-1 in the FIH study news.cision.com/aptahem/r/ap… #BioStockSwe #lifescience #Aptahem

Aptahem reports promising outcome from the additional analyses on the mechanism on lead candidate...

Aptahem AB (publ) announces today that the results from the additional analyses performed in

news.cision.com
196
Stayble reports last patient last visit in the phase IIb study #BioStockSwe #LifeScience @Stayble biostock.se/en/2023/09/stayb…
1
192
Chordate Medical launches the trademark Ozilia #BioStock_News #LifeScience @ChordateMedical biostock.se/en/2023/09/chord…
1
140
Revolutionizing Vaccine Discovery: New Data Validates @EvaxionBiotech AI Platform, Offering Promise to Reduce Risk and Cost in Infectious Disease Vaccine Development. #BioStock_Swe #lifescience globenewswire.com/news-relea…

Revolutionizing Vaccine Discovery: New Data Validates Evaxion AI Platform, Offering Promise to...

Evaxion is the first organization to validate an AI model that outcompetes state-of-the-art vaccine developmentEvaxion's AI model predicts vaccine efficacy...

globenewswire.com
107
SynAct Pharma’s CEO comments on EXPAND data #BioStockSwe #LifeScience #SynActPharma biostock.se/en/2023/09/synac…
570
Stayble Therapeutics enrols the first patient in herniated disc study #BioStockSwe #LifeScience @Stayble biostock.se/en/2023/09/stayb…

Stayble enrolls the first patient in herniated disc study 

Stayble Therapeutic enrolls the first patient in the phase Ib study with STA363 on disc herniation. CEO Gerward comments on the milestone

biostock.se
105
Lipum reports Q2 and increases the pace #BioStockSwe #LifeScience @lipumpharma biostock.se/en/2023/09/lipum…
71
BiBB coming off strong first half of 2023 biostock.se/en/2023/08/bibb-… #lifescience #BioStockSwe @bibbinstruments
117
Alligator Bioscience expands orphan designation to Europe biostock.se/en/2023/08/allig… #lifescience #BioStockSwe @AlligatorBio
81
Lipum publishes important results in journal #BioStockNews #LifeScience @lipumpharma biostock.se/en/2023/08/lipum…
72
Progress for Stayble Therapeutics in the second quarter #BioStockNews #LifeScience @Stayble biostock.se/en/2023/08/progr…

Progress for Stable Therapeutics in the second quarter

Second quarter was a busy period for Stayble Therapeutics with several important achievements, for example a successful capital raise

biostock.se
59
Enzymatica’s CEO comments on promising in-vitro data for ColdZyme #BioStockSwe #LifeScience @Enzymatica_AB biostock.se/en/2023/08/enzym…

Enzymatica's CEO comments on promising in-vitro data for ColdZyme

Interview with Enzymatica's CEO Claus Egstrand on the study at Medical University of Innsbruck showing that ColdZyme breaks the infection cycle

biostock.se
71
Evaxion reaches key milestones during summer biostock.se/en/2023/08/evaxi… #BioStockSwe #lifescience @EvaxionBiotech
32
Iconovo on the way to profitability #BioStock_News #LifeScience #Iconovo biostock.se/en/2023/08/icono…

Iconovo on the way to profitability

Iconovo's CEO Johan Wäborg regarding the goal to achieve profitability in 2026 and revenues of 250 MSEK in 2027, with an EBITDA margin of 50%

biostock.se
103
International specialist congress and upcoming milestones for @ChordateMedical #BioStockSwe #LifeScience biostock.se/en/2023/08/inter…
44
Dicot gets green light for start of phase I study #BioStock_News #LifeScience biostock.se/en/2023/08/dicot…
29
Arcede hopes to reach larger market than existing drugs #BioStock_News #LifeScience biostock.se/en/2023/08/arced…
35
Aqilion has completed Phase 1 study with AQ280 within the Regulus program #BioStock_News #lifescience #Aqilion news.cision.com/aqilion/r/aq…

Aqilion has completed Phase 1 study with AQ280 within the Regulus program

AQILION (publ) announces today that it has successfully completed the first clinical study in

news.cision.com
28
Respiratorius’ CEO comments on the second quarter #BioStock_News #lifescience biostock.se/en/2023/08/respi…
117
Aptahem comments on the paused phase I study biostock.se/en/2023/07/aptah… #lifescience #BioStockSwe #Aptahem
50
Load more